228
Participants
Start Date
May 3, 2018
Primary Completion Date
August 17, 2021
Study Completion Date
September 8, 2021
Abaloparatide
Abaloparatide is a synthetic peptide that is a potent and selective activator of the parathyroid hormone 1 receptor signaling pathway.
Placebo
Abaloparatide-matched placebo.
SUNY Upstate Medical University, Syracuse
Altoona Center For Clinical Research, Duncansville
MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
Hunter Holmes McGuire VA Medical Center, Richmond
PMG Research of Cary, LLC, Cary
PMG Research of Wilmington, LLC, Wilmington
Center For Advanced Research & Education, Gainesville
Meridian Clinical Research, Savannah
Indago Research & Health Center, Inc., Hialeah
Baptist Diabetes Associates, Pa, Miami
University of Alabama at Birmingham, Birmingham
Azienda ospedaliera universitaria integrata di verona(AOUI), Verona
Ohio State University Medical Center, Columbus
Azienda ospedaliera universitaria Careggi, Florence
Azienda Ospedaliera Universitaria Senese-Policlincio Santa Maria Alle Scotte, Siena
University of Wisconsin Osteoporosis Clinical Research Program, Madison
Northwestern University, Chicago
The University of Chicago, Chicago
Centex Studies, Inc., Houston
Centex Studies, Inc, McAllen
Panorama Orthopedics & Spine Center, Golden
NZOZ Nasz Lekarz, Torun
New Mexico Clinical Research & Osteoporosis Center, Inc., Albuquerque
Alta California Medical Group, Simi Valley
Diablo Clinical Research, Inc., Walnut Creek
Marin Endocrine Care & Research, Inc., Greenbrae
Krakowskie Centrum Medyczne Sp. z o.o., Krakow
Synexus Polska Sp. z o.o. Oddzial w Warszawie, Warsaw
Zdrowie Osteo-Medic s.c. Lidia I Artur Racewicz, Agnieszka I Jerzy Supronik, Bialystok
ClinicMed Daniluk, Nowak Sp.j., Bialystok
Centrum Leczenia Osteoporozy Klinika Zdrowej Kosci, Lodz
ETG Siedlce, Siedlce
Lubelskie Centrum Diagnostyczne, Świdnik
Synexus Polska Sp z o.o Oddzial we Wroclawiu, Wroclaw
Radius Health, Inc.
INDUSTRY